|
|
#1
09-30-2016, 04:51 PM
|
|||
|
|||
Regeneron?s Eylea combination therapy fails mid-stage study
Regeneron?s Eylea combination therapy fails mid-stage study
Sept 30 (Reuters) - Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug,Eylea, was inferior to Eylea alone in a mid-stage trialinvolving patients with wet age-related macular degeneration(AMD), a leading cause of blindness. ??????? ??????: Regeneron?s Eylea combination therapy fails mid-stage study || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري